Trump administration to create board to oversee NIH grant funding
HEALTHCARE

Trump administration to create board to oversee NIH grant funding

Sep 21, 2026Updated 7:28am ET

President Donald Trump is reportedly preparing an executive order to create a new board that can approve or veto National Institutes of Health grants, a change that would give political appointees more direct control over which medical research projects get federal funding.

President Donald Trump is reportedly preparing an executive order to create a new board that can approve or veto National Institutes of Health grants, a change that would give political appointees more direct control over which medical research projects get federal funding.

Corroboration

LowMedHigh
The New York TimesThe GuardianAmerican Civil Liberties UnionAdnDetroit Local NewsEI

Confirmed by 13+ sources.

What This is

  • Trump has directed White House budget director Russell Vought to draft an executive order creating a board to decide which NIH research grants are funded.
  • The board would reportedly include political appointees such as Vought and NIH director Jay Bhattacharya, and would require unanimous approval of grant awards.
  • The plan would shift power away from NIH’s usual system, where outside scientific experts review proposals and score them on merit.
  • NIH has said existing grants would not be rescinded, even as internal debate continues about additional review of NIH funding decisions.
  • Researchers have filed a federal class-action lawsuit alleging NIH used a 235-term keyword list to flag, renegotiate, or terminate grants tied to topics like equity, gender identity, and climate change.
  • One example cited in coverage is the early termination of an Alzheimer’s study in Pittsburgh involving about 600 mostly Black, low-income participants, which researchers say could delay analysis and diagnoses.

Why This Matters

  • How NIH chooses grants shapes what diseases, communities, and treatments get studied first.
  • Greater White House control would blur the line between scientific judgment and political power in federal research spending.
  • Keyword-based screening raises basic free-speech questions about whether the government can punish research topics it dislikes.
  • Abrupt grant changes can waste years of work and disrupt studies that rely on steady funding and long-term patient follow-up.

Who else would want to know this?